- Home
- HITI vs FENC Comparison
HITI vs FENC Comparison
Compare HITI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- FENC
- Stock Information
- Founded
- HITI 2009
- FENC 1996
- Country
- HITI Canada
- FENC United States
- Employees
- HITI N/A
- FENC N/A
- Industry
- HITI
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HITI
- FENC Health Care
- Exchange
- HITI Nasdaq
- FENC Nasdaq
- Market Cap
- HITI 187.8M
- FENC 229.8M
- IPO Year
- HITI N/A
- FENC 2001
- Fundamental
- Price
- HITI $2.30
- FENC $8.34
- Analyst Decision
- HITI Strong Buy
- FENC Strong Buy
- Analyst Count
- HITI 2
- FENC 2
- Target Price
- HITI $4.75
- FENC $13.00
- AVG Volume (30 Days)
- HITI 283.6K
- FENC 83.2K
- Earning Date
- HITI 06-16-2025
- FENC 08-12-2025
- Dividend Yield
- HITI N/A
- FENC N/A
- EPS Growth
- HITI N/A
- FENC N/A
- EPS
- HITI N/A
- FENC N/A
- Revenue
- HITI $398,202,371.00
- FENC $30,912,000.00
- Revenue This Year
- HITI $12.43
- FENC $0.85
- Revenue Next Year
- HITI $11.39
- FENC $55.16
- P/E Ratio
- HITI N/A
- FENC N/A
- Revenue Growth
- HITI 9.22
- FENC N/A
- 52 Week Low
- HITI $1.57
- FENC $3.96
- 52 Week High
- HITI $3.62
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- HITI 53.11
- FENC 58.31
- Support Level
- HITI $2.14
- FENC $7.53
- Resistance Level
- HITI $2.35
- FENC $8.68
- Average True Range (ATR)
- HITI 0.08
- FENC 0.49
- MACD
- HITI -0.01
- FENC -0.04
- Stochastic Oscillator
- HITI 68.97
- FENC 63.18
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.